VolitionRx
Business Services · Nevada, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1489 W Warm Springs Rd Ste 110, Henderso...Phone Number
(702) 425-1561Website
www.volition.comRevenue
<$5 MillionStock Symbol
VNRXIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About VolitionRx
Volition is a multinational epigenetic company focused on advancing the science of epigenetics. It is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, the company is developing and commercializing simple, easy-to-use, cost-effective blood tests designed to help diagnose and monitor a range of diseases, including certain cancers and conditions associated with NETosis, such as sepsis.Explore more
VolitionRx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is VolitionRx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once VolitionRx has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if VolitionRx had a recent Job posting/layoffs
VolitionRx, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at VolitionRx
Check out if VolitionRx is spiking on competitors!
Product Launch: Get notified when VolitionRx launches new products
Check if VolitionRx has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on VolitionRx recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined VolitionRx as Masked Content
Find 3 more new buyers
Compare Similar Companies to VolitionRx
Compare insights from companies similar to VolitionRx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
VolitionRx
<$5M
51-200
Public
$11.3M
2010
Tom ButeraCEO (Volition Veterinary Diagnostics Development LLC)
Company Profile Activity
Activity Insights
VolitionRx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
VolitionRx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about VolitionRx.
VolitionRx financials insights
Gather financial insights about VolitionRx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Private Equity
$1.5M
2023
Debt
$5.5M
2026
Stock/Share Issuance
$2M
Other Financing Round
$2.3M
VolitionRx Tech Stack
A closer look at the technologies used by VolitionRx
Most Recent Scoops
Earnings
VolitionRx has reported total operating expenses of $4.6 million for Q2 2026, compared to $6.7 million in Q2 2025, representing a 32% year-on-year reduction driven by a cost reduction program that included a 27% decrease in headcount compared to the same period in 2025.
Earnings, Spending/Investment, Layoffs, Finance
Project
VolitionRx has outlined the next development stages for its Nu.Q NETs lateral flow assay, which include transitioning the assay to research use only status followed by clinical validation across three independent hospitals, with the clinical validation phase expected to commence in early 2027.
Product Development, Medical Research, Clinical Operations
Earnings
VolitionRx has reported net cash used in operating activities of $5.2 million for Q2 2026, compared to $6.3 million in Q2 2025, with cash and cash equivalents totaling approximately $2.8 million at the end of Q2 2026, up from $1.1 million as of December 31, 2025.
Earnings, Finance, Financial Operations
Project
VolitionRx has participated in its first pre-submission meeting with French authorities as part of its reimbursement submission for Nu.Q Lung Cancer, supported by collaborators at Hospices Civils de Lyon, with a follow-up meeting and formal submission anticipated by Q3 of this year.
Medical Research, Pharmaceuticals
Earnings
Earnings, Accounting, Financial Reporting, Finance, Financial Operations
VolitionRx News & Media
VolitionRx Limited Announces Pre-Payment in Full of $7.5 million Senior Secured Convertible Promissory Note Due May 20, 2027
Reduces Equity Overhang HENDERSON, Nev., Sept. 14, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces the full pre-payment in cash of the outstanding balance on its senior secured convertible promissory note,...Volition Presents Early Stage I Solid Cancer Detection at the ESMO MAP Conference
Targets $36 Billion TAM in Early Cancer Detection and MRD. HENDERSON, Nev., Sept. 10, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces the presentation of an abstract1 at the European Society of Medical Oncology...VolitionRx secures waiver on ATM share cap | VNRX 8-K Filing - Stock Titan
Lind waiver lets VolitionRx sell above its $10M ATM cap as permitted transactions and waives related defaults, with no further price resets.VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets
112% H1 Revenue Growth, Advance Toward $5 Million Veterinary Milestone, Newly Announced Collaboration and Active Licensing Discussions with More Than a Dozen Global Diagnostic Leaders HENDERSON, Nev., Aug. 26, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding VolitionRx
Sign Up For FreeTo access detailed company insights
Volition is a multinational epigenetic company focused on advancing the science of epigenetics. It is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, the company is developing and commercializing simp... Read More
